These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36430639)

  • 1. Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk.
    Lan WH; Lin TY; Yeh JA; Feng CL; Hsu JT; Lin HJ; Kuo CJ; Lai CH
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
    Foretz M; Guigas B; Viollet B
    Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.
    Nasri H; Baradaran A; Ardalan MR; Mardani S; Momeni A; Rafieian-Kopaei M
    Iran J Kidney Dis; 2013 Nov; 7(6):423-8. PubMed ID: 24241085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of metformin on glomerular podocytes in diabetes.
    Rogacka D; Piwkowska A
    Biochem Pharmacol; 2021 Oct; 192():114687. PubMed ID: 34274355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and application of metformin in kidney diseases: An update.
    Song A; Zhang C; Meng X
    Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on mode of action of metformin in modulation of meta-inflammation and inflammaging.
    Khodadadi M; Jafari-Gharabaghlou D; Zarghami N
    Pharmacol Rep; 2022 Apr; 74(2):310-322. PubMed ID: 35067907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target.
    Boyle JG; Salt IP; McKay GA
    Diabet Med; 2010 Oct; 27(10):1097-106. PubMed ID: 20854376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer research. Cancer prevention with a diabetes pill?
    Taubes G
    Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis.
    Eriksson L; Nyström T
    Cardiovasc Diabetol; 2014 Nov; 13():152. PubMed ID: 25391818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature.
    Tseng CH
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin; an old antidiabetic drug with new potentials in bone disorders.
    Bahrambeigi S; Yousefi B; Rahimi M; Shafiei-Irannejad V
    Biomed Pharmacother; 2019 Jan; 109():1593-1601. PubMed ID: 30551413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does long-term metformin usage reduce gastric cancer risk?
    Coban S
    Turk J Gastroenterol; 2014 Feb; 25(1):125. PubMed ID: 24918151
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug].
    Winkler G
    Orv Hetil; 2016 Jun; 157(23):882-91. PubMed ID: 27233831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice].
    Kuznetsov KO; Safina ER; Gaimakova DV; Frolova YS; Oganesyan IY; Sadertdinova AG; Nazmieva KA; Islamgulov AH; Karimova AR; Galimova AM; Rizvanova EV
    Probl Endokrinol (Mosk); 2022 Jul; 68(5):45-55. PubMed ID: 36337018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2015; 15(3):196-205. PubMed ID: 25772174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
    Vona-Davis L; Rose DP
    Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
    Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.